Browse by author
Lookup NU author(s): Professor Raj KalariaORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 IOS Press and the authors. All rights reserved.Background: Time and resource limitations prevent cognitive assessment in acute-to-subacute settings, even in comprehensive stroke centers. Objective: To assess cognitive function in acute stroke patients undergoing routine clinical, laboratory, and radiological investigations, with a view to improving post-stroke care and treatment. Methods: Sixty-nine patients (72.6±11.1 years; 65% male) were prospectively enrolled within 14 days of acute ischemic stroke. Patients with altered consciousness, aphasia, or dysarthria were excluded. Clinical features including modified Rankin and NIH stroke scales, and vascular risk factors were assessed, as well as neuroimaging parameters by semi-quantitative evaluation of medial temporal lobe atrophy (MTLA) using MRA source images, FLAIR images for white matter changes (Fazekas scores), and T2. images for cerebral microbleeds. Neuropsychological screening was conducted using the Montreal Cognitive Assessment (MoCA) test. Univariate and multivariate analyses were used to evaluate the influence of variables on MoCA total and subscale scores. Results: Lower MoCA scores of 22 or less were associated with MTLA [OR (95%CI), 5.3 (1.0.27.5); p = 0.045], education years [OR (95%CI), 0.71 (0.55.0.91); p = 0.007], and modified Rankin scale at discharge [OR (95%CI), 2.4 (1.3.4.5); p = 0.007]. The delayed recall MoCA score was correlated with MTLA (r =-0.452, p < 0.001), periventricular (r =-0.273, p = 0.024), and deep (r =-0.242, p = 0.046), white matter changes. Conclusions: MTLA, together with lower educational history, are quick indicators of amnestic cognitive impairment after stroke. The association between cognitive impairment and physical disability at discharge may signify the importance of earlier cognitive assessment.
Author(s): Takahashi Y, Saito S, Yamamoto Y, Uehara T, Yokota C, Sakai G, Nishida N, Takahashi R, Kalaria RN, Toyoda K, Nagatsuka K, Ihara M, Friedland R
Publication type: Article
Publication status: Published
Journal: Journal of Alzheimer's Disease
Year: 2019
Volume: 67
Issue: 2
Pages: 621-629
Online publication date: 22/01/2019
Acceptance date: 12/11/2018
ISSN (print): 1387-2877
ISSN (electronic): 1875-8908
Publisher: IOS Press
URL: https://doi.org/10.3233/JAD-180976
DOI: 10.3233/JAD-180976
PubMed id: 30584149
Altmetrics provided by Altmetric